The collaboration will leverage proprietary stem cell lines developed by Medistem to screen monoclonal antibodies for therapeutic activity in the area of regenerative medicine. Medistem CEO Thomas Ichim
Ustekinumab demonstrated effectiveness and was tolerated in patients inadequately responsive to methotrexate, and improved quality of life outcomes in patients transitioned from methotrexate in the 52-week TRANSIT study.
Vortioxetine is under investigation as an antidepressant with multimodal activity that is thought to work through receptor activity modulation and reuptake inhibition. Takeda Global Research & Development Center
Regeneron chief scientific officer and Regeneron Laboratories president George Yancopoulos said the approval of Eylea in Japan presents new treatment option for wet AMD patients and physicians. "We
The integrated chemistry data will run on Roche’s infrastructure and inside the Roche firewall to provide high performance and security. With the integration, Roche researchers’ will be able
The company will use the Medidata Solutions (MDSO) platform in phase II clinical trial to test a vaccine. The Medidata’s integrated solutions are expected to drive trial efficiencies
BASF Nutrition & Health division president Walter Dissinger was quoted by Daily Record as saying that by moving the headquarters of company’s global business unit to the US,
3 Second Health is made up of 13 vitamins, 70 plus minerals and has citrus flavour. Pureform 1000 managing member Erik Levine said the company believes 3 Second
Under the agreement, Bayer will be responsible for any subsequent clinical development and commercialization. For the development, Evotec will receive €12m as an upfront payment and may also
As part of the renewed agreement, Elite will carry on with manufacturing and packaging for TPN’s methadone hydrochloride, 10 mg tablets through 31 December 2014. Ascend Laboratories and
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.